Overview


According to FutureWise analysis the market for Multiplex Detection Immunoassays in 2023 is US$ 2.02 billion, and is expected to reach US$ 3.66 billion by 2031 at a CAGR of 7.72%.

The wide range of applications of superior detection immunoassays over conventional detection assays based on linear maintenance for many orders has been the primary factor responsible for the multiplex detection immunoassays market growth. Furthermore, the rising prevalence of chronic disorders like Alzheimer’s and cancer along with the creation of simultaneous, time-saving and cost-effective measurement of different analytes in one sample. Multiplex detection assays are suited for diagnosing autoimmune and heterogeneous diseases. In addition, these assays are utilised for identifying and measuring analytes like inflammatory proteins, kinase, growth factors and cytokine in animals. Such factors shall bolster the proliferation of the market.

  • F. Hoffmann-La Roche AG
  • QIAGEN N.V
  • EMD Millipore
  • Microsynh AG
  • Bio-Rad
  • Thermo Fisher Scientific Inc.
  • Luminex Corporation
  • BD Biosciences

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Assay Type

  • Planar Assays
  • Bead-Based Assays

By Technique

  • Nuclei Acid Based Technique
  • Protein Based Technique
  • Biosensor Based Technique

By Application

  • Disease Testing
  • Food Contamination Testing
  • Research and Development
  • Veterinary Disease Testing

By End User

  • Pharmaceutical Companies
  • Clinical Research Organizations
  • Food and Beverages Companies
  • Academic Research Institutes
  • Diagnostic Centers
  • Biotechnology Centers

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

The market is categorised into assay type, technique, application, end user and region. The assay type segment is fragmented into planar assay and bead-based assay. The planar assay segment is sub-segmented into blends protein arrays and antibody arrays while the bead-based assay segment is divided into magnetic bead-based assay and non-magnetic bead-based assay. The technique segment is diversified into nuclei acid-based technique, protein-based technique and biosensor-based technique. The application segment is bifurcated into disease testing, food contamination testing, research and development and veterinary disease testing. The end user segment is segmented into pharmaceutical companies, clinical research organizations, food and beverage companies, academic research institutes, diagnostic centres and biotech centres.

The North America region is predicted to hold the largest multiplex detection immunoassays market share owing to advancements in immunoassay technology, increased disposable income of general population and a strong presence of major market players in the region. Furthermore, rise in the number of diagnostic centres shall boost the market growth substantially.

  • Tier 1 players-established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the global multiplex detection immunoassays market by assay type, by technique, by application, by end user and by region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
  • To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers, and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

 

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Multiplex Detection Immunoassays Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Multiplex Detection Immunoassays Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Multiplex Detection Immunoassays Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Multiplex Detection Immunoassays Market, By Assay Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Planar Assays
        2. Bead-Based Assays

  • 8.   Multiplex Detection Immunoassays Market, By Technique Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Nuclei Acid Based Technique
        2. Protein Based Technique
        3. Biosensor Based Technique

  • 9.   Multiplex Detection Immunoassays Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Disease Testing
        2. Food Contamination Testing
        3. Research and Development
        4. Veterinary Disease Testing

  • 10.   Multiplex Detection Immunoassays Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Pharmaceutical Companies
        2. Clinical Research Organizations
        3. Food and Beverages Companies
        4. Academic Research Institutes
        5. Diagnostic Centers
        6. Biotechnology Centers

  • 11.   North America Multiplex Detection Immunoassays Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Multiplex Detection Immunoassays Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Multiplex Detection Immunoassays Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Multiplex Detection Immunoassays Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Multiplex Detection Immunoassays Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. F. Hoffmann-La Roche AG
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. QIAGEN N.V
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. EMD Millipore
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Microsynh AG
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Bio-Rad
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Thermo Fisher Scientific Inc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Luminex Corporation
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. BD Biosciences
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients